Publications by authors named "Adele Fielding"

Claim this Profile
C
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network.
Alexandra Smith, Clare Frobisher, Abraham Varghese, Andy Rawstron, Simon Crouch, Adele Fielding

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblasts.
Richard J Burt, Aditi Dey, Ayse Akarca, Hermione Allen, Rodothea Amerikanou, Adele K Fielding

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.
Sunniyat Rahman, Gianna Bloye, Nadine Farah, Jonas Demeulemeester, Joana R Costa, Adele K Fielding

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations.
Alesia A Khan, Daniel James, Vibeke Andresen, Julie Atkey, Rachel Bradbury, Adele K Fielding

Am J Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia.
Bela Patel, Amy A Kirkwood, Clare J Rowntree, Krisztina Z Alapi, Emilio Barretta, Adele K Fielding

Hemasphere· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele Fielding

Blood· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele Fielding

Blood· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.
Amir Enshaei, Melvin Joy, Ellie Butler, Amy A Kirkwood, Monica Messina, Adele K Fielding

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform.
Amir Enshaei, Javier Martinez Elicegui, Esther Anguiano, Jude Gibson, Sulaiman Lawal, Adele K Fielding

Leukemia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Daniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, Emilio Barretta, Thomas Creasey, Adele K Fielding

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission.
David I Marks, Anna Castleton, Eduardo Olavarria, Maria Gilleece, Adele Fielding

BMJ Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.
Tarec Christoffer El-Galaly, Verena I Gaidzik, Mihnea-Alexandru Gaman, Darko Antic, Jessica Okosun, Adele K Fielding

Hemasphere· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.
Abdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, Aude-Anais Olijnik, Michela Colombo, Adele K Fielding

Cancer Discov· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Thomas Creasey, Emilio Barretta, Sarra L Ryan, Ellie Butler, Amy A Kirkwood, Adele K Fielding

Haematologica· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.
Wei Yee Chan, Catherine Zhu, Emilie Sanchez, Rajeev Gupta, Adele K Fielding

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial.
David I Marks, Amy A Kirkwood, Clare J Rowntree, Melanie Aguiar, Katharine E Bailey, Adele K Fielding

Lancet Haematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.
David I Marks, Laura Clifton-Hadley, Mhairi Copland, Jiaull Hussain, Tobias F Menne, Adele K Fielding

Lancet Haematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Anthony V Moorman, Emilio Barretta, Ellie R Butler, Eleanor J Ward, Katie Twentyman, Adele K Fielding

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK-ing up treatment for CRLF2-R ALL.
Adele K Fielding

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Elisabeth Paietta, Kathryn G Roberts, Victoria Wang, Zhaohui Gu, Georgina A N Buck, Adele K Fielding

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
Thomas Creasey, Amir Enshaei, Karin Nebral, Claire Schwab, Kathryn Watts, Adele K Fielding

Genes Chromosomes Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Rachel J Mitchell, Amy A Kirkwood, Emilio Barretta, Laura Clifton-Hadley, Emma Lawrie, Adele K Fielding

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma.
Thomas A Fox, Ben Carpenter, Mary Taj, Martha Perisoglou, Emma Nicholson, Adele K Fielding

Leuk Lymphoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Pushpendra Goswami, Esther N Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K Fielding

Front Pharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurement.
Jack Bartram, Bela Patel, Adele K Fielding

Semin Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis